Multiple Drug Resistance Tuberculosis in Patients at TB Clinic Sisaket Hospital during 2005 - 2010

Authors

  • ทวีวุฒิ เต็มเอี่ยม Sisaket Hospital

Keywords:

Multiple Drug Resistance Tuberculosis, TB Clinic, Sisaket Hospital

Abstract

Objective of this study were to assess the numbers, prevalence, result of treatment in MDR-TB cases and sensitivity test for TB drugs in TB-clinic Sisaket hospital. Retrospective study was done during October 1st 2005 to September 30th 2010. Analysis with descriptive statistic was used. It was found that there were 38 cases of MDR-TB in study period, 66% was male, average age was 44.8 years, non coinfection with HIV was 97.4%. Domicile outside responsibility subdistrict area was 81.6%. For prevalence of MDR-TB among new cases was 0.19% and prevalence among previously treated cases was 7.01%. Regarding to the sensitivity test for TB-drug, it was found that INH - resistancd 35 cases (92.1%), RFP -resistance 35 cases (92.1%), Streptomycin - resistance 22 cases (57.9%), ETB - resistance 16 cases (42.1%), PZA - resistance 1 case and ofloxacin - resistance 1 case. Result of treatment was as follow:success rate 76.3%, death rate 13.1%, during treatment 7.9% and transfer out 2.6%. Although the death rate was 13.1% but in the future if we could not reduce or control MDR-TB, extensively drug resistance Tuberculosis or XDR-TB would increase and would be more expensive and difficult to treat than MDR-TB.

References

1. World Health Organization, Global TuberculosisControl: surveillance, planning, financing. WHO Report 2010.Geneva: World Health OrganizationDocument, 2010. WHO/HTM/TB/2010.7

2. กรมควบคุมโรค กระทรวงสาธารณสุข. แนวทางการดำเนินงานควบคุมวัณโรคแห่งชาติ. พิมพ์ครั้งที่ 1.
(ฉบับปรับปรุง) กรุงเทพฯ โรงพิมพ์สำนักงานพุทธศาสนาแห่งชาติ, 2548.

3. Payanandana V, Rienthong D, Rienthong S,Ratanavichit L, Kim SJ, Sawert H. Surveillancefor antituberculosis drug resistance in Thailand: result from national survey. Thai J Tuberc Chest Dis. 2000; 21: 1-8.

4. กองวัณโรค. ผลการเฝ้าระวังเชื้อวัณโรคดื้อยา ครั้งที่สอง. 2545.

5. คลินิกวัณโรค โรงพยาบาลศรีสะเกษ. รายงานผลการรักษาผู้ป่วยวัณโรคดื้อยา ปี 2548- 2553.

6. World Health Organization. Global tuberculosisControl 2009 Epidemiology strategy Financing.Geneva, Switzerland. 2009: p40.

7. World Health Organization, Tuberculosis Control in the Western Pacific Region, WHO Report 2008.Geneva: World Health Organization Document,2008.

8. http://wh qlibd oc.wh o.int/ hq/20 08/WHO_HTM_TB_2008.394_eng.pdf

9. O'Donnell MR, Padayatchi N, Master I, OsburnG, Horsburgh CR. Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa. Int J Tuberc Lung Dis. 2009; 13(7): 855-61.

10. Cox H, Kalon S, Allamuratova S, et al, Multidrugresistant Tuberculosis Treatment Ooutcomes in Karakalpakstan, Uzbedistan: Treatment Complexity and XDR-TB among Treatment Failures, PLoS ONEE, 2007. 2(11):p. e1126.

11. van Rie A, Warren R, Richardson N, et al, Classification of drug-resistant tuberculosis in an epidemic area. Lancet. 2000; 356: 22-25.

Downloads

Published

2011-12-30

How to Cite

1.
เต็มเอี่ยม ท. Multiple Drug Resistance Tuberculosis in Patients at TB Clinic Sisaket Hospital during 2005 - 2010. Dis Control J [Internet]. 2011 Dec. 30 [cited 2024 May 2];37(4):236-42. Available from: https://he01.tci-thaijo.org/index.php/DCJ/article/view/155436

Issue

Section

Original Article